Plunkett Research Online: InNexus Biotechnology Inc.

INNEXUS BIOTECHNOLOGY INC. (IXSBF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications......


INNEXUS BIOTECHNOLOGY INC.

Ticker: IXSBF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 480 862-7500
Fax: 604 687-0043
Address: 1500 Royal Centre
Vancouver, BC V6E 4N7 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Jeff MorhetCEO/Chairman of the Board/Director/President
David PetullaCFO/Vice President
See More
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications......See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture